Your browser doesn't support javascript.
loading
Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and ß.
Rossi, V; Bellastella, G; De Rosa, C; Abbondanza, C; Visconti, D; Maione, L; Chieffi, P; Della Ragione, F; Prezioso, D; De Bellis, A; Bellastella, A; Sinisi, A A.
Affiliation
  • Rossi V; Dipartimento di Internistica Clinica e Sperimentale, Sezione di Endocrinologia ed Andrologia Medica, Universita' Federico II, Napoli, Italy.
J Cell Physiol ; 226(5): 1334-9, 2011 May.
Article in En | MEDLINE | ID: mdl-20945400

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Prostatic Neoplasms / Signal Transduction / Apoptosis / Antineoplastic Agents, Hormonal / Raloxifene Hydrochloride / Selective Estrogen Receptor Modulators / Estrogen Receptor alpha / Estrogen Receptor beta / Cell Proliferation Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: J Cell Physiol Year: 2011 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Prostatic Neoplasms / Signal Transduction / Apoptosis / Antineoplastic Agents, Hormonal / Raloxifene Hydrochloride / Selective Estrogen Receptor Modulators / Estrogen Receptor alpha / Estrogen Receptor beta / Cell Proliferation Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: J Cell Physiol Year: 2011 Document type: Article